Par Drugs and Chemicals Limited (NSE:PAR)
India · Delayed Price · Currency is INR 94.60
-1.80 (-1.87%)
Jun 19, 2026, 3:29 PM IST
Par Drugs and Chemicals Market Cap
Par Drugs and Chemicals has a market cap or net worth of 1.16 billion as of June 18, 2026. Its market cap has decreased by -6.37% in one year.
Market Cap
1.16B
Enterprise Value
745.59M
Revenue
1.04B
Ranking
n/a
PE Ratio
8.88
Stock Price
94.60
Market Cap Chart
Since May 16, 2019, Par Drugs and Chemicals's market cap has increased from 310.38M to 1.16B, an increase of 275.02%. That is a compound annual growth rate of 20.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 1.16B | -6.58% |
| Dec 31, 2025 | 1.25B | -49.09% |
| Dec 31, 2024 | 2.45B | -7.79% |
| Dec 29, 2023 | 2.65B | 42.80% |
| Dec 30, 2022 | 1.86B | -24.94% |
| Dec 31, 2021 | 2.48B | 451.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jagsonpal Pharmaceuticals | 14.25B |
| Sigachi Industries | 8.77B |
| Bafna Pharmaceuticals | 3.79B |
| Valiant Laboratories | 3.69B |
| Nectar Lifesciences | 2.22B |
| Brooks Laboratories | 1.96B |
| Alpa Laboratories | 1.43B |
| Balaxi Pharmaceuticals | 1.31B |